Does surgery affect systemic immune response? a perioperative analysis of TGF-β, IL-8 and CD45RO

BackgroundThe options of (neo-)adjuvant immunotherapy in addition to surgery in the treatment of oral squamous cell carcinoma (OSCC) are steadily increasing, but patients do not always respond to therapy as intended. The objectives of this study were to investigate the systemic perioperative course...

Full description

Bibliographic Details
Main Authors: Leah Trumet, Jutta Ries, Niclas Ivenz, Philip Sobl, Falk Wehrhan, Rainer Lutz, Marco Kesting, Manuel Weber
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1307956/full
_version_ 1797401420746457088
author Leah Trumet
Leah Trumet
Leah Trumet
Jutta Ries
Jutta Ries
Niclas Ivenz
Niclas Ivenz
Philip Sobl
Philip Sobl
Falk Wehrhan
Falk Wehrhan
Rainer Lutz
Rainer Lutz
Marco Kesting
Marco Kesting
Manuel Weber
Manuel Weber
author_facet Leah Trumet
Leah Trumet
Leah Trumet
Jutta Ries
Jutta Ries
Niclas Ivenz
Niclas Ivenz
Philip Sobl
Philip Sobl
Falk Wehrhan
Falk Wehrhan
Rainer Lutz
Rainer Lutz
Marco Kesting
Marco Kesting
Manuel Weber
Manuel Weber
author_sort Leah Trumet
collection DOAJ
description BackgroundThe options of (neo-)adjuvant immunotherapy in addition to surgery in the treatment of oral squamous cell carcinoma (OSCC) are steadily increasing, but patients do not always respond to therapy as intended. The objectives of this study were to investigate the systemic perioperative course of the biomarkers CD45RO, TGF-β, and IL-8 in non-tumor-related minor and tumor-related major maxillofacial surgery and to perform association analyses with demographic and histomorphologic parameters. A deeper understanding of surgery-related changes in various of different immune biomarkers could help to better understand the immunologic consequences of surgery which could influence immunotherapeutic protocols.MethodsPeripheral whole blood from 38 patients was analyzed by real-time quantitative polymerase chain reaction (RT-qPCR) at five different timepoints before and after maxillofacial surgery to detect changes in mRNA expression of the biomarkers TGF-β, IL-8 and CD45RO. All patients underwent general anesthesia to undergo either resection and free flap reconstruction for OSCC or minor maxillofacial surgery (controls). Statistical analysis was done using Mann-Whitney-U test, Wilcoxon test, and Spearman’s correlation.ResultsCompared to the preoperative expression, there was a significant postoperative downregulation of CD45RO, TGF-β and IL-8 until the 4th postoperative day (p ≤ 0.003) in OSCC patients. For TGF-β and IL-8, the reduction in expression was significant (p ≤ 0.004) compared to controls. By postoperative day 10, all analyzed parameters converged to baseline levels. Only CD45RO still showed a significant downregulation (p=0.024). Spearman analysis revealed a significant correlation between increased duration of surgery and perioperative reduction in peripheral blood expression of CD45RO, TGF-β and IL-8 (p ≤ 0.004). Perioperative changes in TGF-β and PD-L1 expression were shown to be not correlated. Preoperative TGF-β expression was significantly lower in patients with lymph node metastases (p=0.014).ConclusionWith regard to the analyzed parameters, major oncologic head-and-neck surgery does not seem to have long-lasting systemic immunologic effects. Reduced CD45RO might be an expression of transient systemic immunosuppression in response to major surgery. The association of duration of surgery with expression changes of immunologic markers supports efforts to keep the duration of surgery as short as possible. As perioperative TGF-β and PD-L1 expression changes are not associated, these results support further investigation of a combined perioperative anti-PD-1 and anti-TGF-β immunotherapy.
first_indexed 2024-03-09T02:09:50Z
format Article
id doaj.art-72e746cdef664defaf5514106d357b33
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-03-09T02:09:50Z
publishDate 2023-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-72e746cdef664defaf5514106d357b332023-12-07T14:02:41ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-12-011310.3389/fonc.2023.13079561307956Does surgery affect systemic immune response? a perioperative analysis of TGF-β, IL-8 and CD45ROLeah Trumet0Leah Trumet1Leah Trumet2Jutta Ries3Jutta Ries4Niclas Ivenz5Niclas Ivenz6Philip Sobl7Philip Sobl8Falk Wehrhan9Falk Wehrhan10Rainer Lutz11Rainer Lutz12Marco Kesting13Marco Kesting14Manuel Weber15Manuel Weber16Department of Oral and Cranio-Maxillofacial Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, GermanyDeutsches Zentrum Immuntherapie (DZI) and Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, GermanyDepartment of Operative Dentistry and Periodontology, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Erlangen, GermanyDepartment of Oral and Cranio-Maxillofacial Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, GermanyDeutsches Zentrum Immuntherapie (DZI) and Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, GermanyDepartment of Oral and Cranio-Maxillofacial Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, GermanyDeutsches Zentrum Immuntherapie (DZI) and Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, GermanyDepartment of Oral and Cranio-Maxillofacial Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, GermanyDeutsches Zentrum Immuntherapie (DZI) and Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, GermanyDepartment of Oral and Cranio-Maxillofacial Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, GermanyPrivate Office for Maxillofacial Surgery, Freiberg, GermanyDepartment of Oral and Cranio-Maxillofacial Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, GermanyDeutsches Zentrum Immuntherapie (DZI) and Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, GermanyDepartment of Oral and Cranio-Maxillofacial Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, GermanyDeutsches Zentrum Immuntherapie (DZI) and Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, GermanyDepartment of Oral and Cranio-Maxillofacial Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, GermanyDeutsches Zentrum Immuntherapie (DZI) and Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, GermanyBackgroundThe options of (neo-)adjuvant immunotherapy in addition to surgery in the treatment of oral squamous cell carcinoma (OSCC) are steadily increasing, but patients do not always respond to therapy as intended. The objectives of this study were to investigate the systemic perioperative course of the biomarkers CD45RO, TGF-β, and IL-8 in non-tumor-related minor and tumor-related major maxillofacial surgery and to perform association analyses with demographic and histomorphologic parameters. A deeper understanding of surgery-related changes in various of different immune biomarkers could help to better understand the immunologic consequences of surgery which could influence immunotherapeutic protocols.MethodsPeripheral whole blood from 38 patients was analyzed by real-time quantitative polymerase chain reaction (RT-qPCR) at five different timepoints before and after maxillofacial surgery to detect changes in mRNA expression of the biomarkers TGF-β, IL-8 and CD45RO. All patients underwent general anesthesia to undergo either resection and free flap reconstruction for OSCC or minor maxillofacial surgery (controls). Statistical analysis was done using Mann-Whitney-U test, Wilcoxon test, and Spearman’s correlation.ResultsCompared to the preoperative expression, there was a significant postoperative downregulation of CD45RO, TGF-β and IL-8 until the 4th postoperative day (p ≤ 0.003) in OSCC patients. For TGF-β and IL-8, the reduction in expression was significant (p ≤ 0.004) compared to controls. By postoperative day 10, all analyzed parameters converged to baseline levels. Only CD45RO still showed a significant downregulation (p=0.024). Spearman analysis revealed a significant correlation between increased duration of surgery and perioperative reduction in peripheral blood expression of CD45RO, TGF-β and IL-8 (p ≤ 0.004). Perioperative changes in TGF-β and PD-L1 expression were shown to be not correlated. Preoperative TGF-β expression was significantly lower in patients with lymph node metastases (p=0.014).ConclusionWith regard to the analyzed parameters, major oncologic head-and-neck surgery does not seem to have long-lasting systemic immunologic effects. Reduced CD45RO might be an expression of transient systemic immunosuppression in response to major surgery. The association of duration of surgery with expression changes of immunologic markers supports efforts to keep the duration of surgery as short as possible. As perioperative TGF-β and PD-L1 expression changes are not associated, these results support further investigation of a combined perioperative anti-PD-1 and anti-TGF-β immunotherapy.https://www.frontiersin.org/articles/10.3389/fonc.2023.1307956/fullperioperative systemic changes of signaling pathways immune toleranceOSCCHNSCCsurgeryinterleukinsoral surgery
spellingShingle Leah Trumet
Leah Trumet
Leah Trumet
Jutta Ries
Jutta Ries
Niclas Ivenz
Niclas Ivenz
Philip Sobl
Philip Sobl
Falk Wehrhan
Falk Wehrhan
Rainer Lutz
Rainer Lutz
Marco Kesting
Marco Kesting
Manuel Weber
Manuel Weber
Does surgery affect systemic immune response? a perioperative analysis of TGF-β, IL-8 and CD45RO
Frontiers in Oncology
perioperative systemic changes of signaling pathways immune tolerance
OSCC
HNSCC
surgery
interleukins
oral surgery
title Does surgery affect systemic immune response? a perioperative analysis of TGF-β, IL-8 and CD45RO
title_full Does surgery affect systemic immune response? a perioperative analysis of TGF-β, IL-8 and CD45RO
title_fullStr Does surgery affect systemic immune response? a perioperative analysis of TGF-β, IL-8 and CD45RO
title_full_unstemmed Does surgery affect systemic immune response? a perioperative analysis of TGF-β, IL-8 and CD45RO
title_short Does surgery affect systemic immune response? a perioperative analysis of TGF-β, IL-8 and CD45RO
title_sort does surgery affect systemic immune response a perioperative analysis of tgf β il 8 and cd45ro
topic perioperative systemic changes of signaling pathways immune tolerance
OSCC
HNSCC
surgery
interleukins
oral surgery
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1307956/full
work_keys_str_mv AT leahtrumet doessurgeryaffectsystemicimmuneresponseaperioperativeanalysisoftgfbil8andcd45ro
AT leahtrumet doessurgeryaffectsystemicimmuneresponseaperioperativeanalysisoftgfbil8andcd45ro
AT leahtrumet doessurgeryaffectsystemicimmuneresponseaperioperativeanalysisoftgfbil8andcd45ro
AT juttaries doessurgeryaffectsystemicimmuneresponseaperioperativeanalysisoftgfbil8andcd45ro
AT juttaries doessurgeryaffectsystemicimmuneresponseaperioperativeanalysisoftgfbil8andcd45ro
AT niclasivenz doessurgeryaffectsystemicimmuneresponseaperioperativeanalysisoftgfbil8andcd45ro
AT niclasivenz doessurgeryaffectsystemicimmuneresponseaperioperativeanalysisoftgfbil8andcd45ro
AT philipsobl doessurgeryaffectsystemicimmuneresponseaperioperativeanalysisoftgfbil8andcd45ro
AT philipsobl doessurgeryaffectsystemicimmuneresponseaperioperativeanalysisoftgfbil8andcd45ro
AT falkwehrhan doessurgeryaffectsystemicimmuneresponseaperioperativeanalysisoftgfbil8andcd45ro
AT falkwehrhan doessurgeryaffectsystemicimmuneresponseaperioperativeanalysisoftgfbil8andcd45ro
AT rainerlutz doessurgeryaffectsystemicimmuneresponseaperioperativeanalysisoftgfbil8andcd45ro
AT rainerlutz doessurgeryaffectsystemicimmuneresponseaperioperativeanalysisoftgfbil8andcd45ro
AT marcokesting doessurgeryaffectsystemicimmuneresponseaperioperativeanalysisoftgfbil8andcd45ro
AT marcokesting doessurgeryaffectsystemicimmuneresponseaperioperativeanalysisoftgfbil8andcd45ro
AT manuelweber doessurgeryaffectsystemicimmuneresponseaperioperativeanalysisoftgfbil8andcd45ro
AT manuelweber doessurgeryaffectsystemicimmuneresponseaperioperativeanalysisoftgfbil8andcd45ro